Green traffic light

Zydus Cadila | Saroglitazar

Zydus’ saroglitazar is approved in India to treat hypertriglyceridemia—high triglyceride levels—in patients with Type 2 diabetes. In a study presented at this year’s American Association for the Study of Liver Diseases meeting, the company tested three doses of the drug against placebo in patients with nonalcoholic fatty liver disease who were also overweight.